Training for staff working at DR-TB management centres.
Training modules
DHS Analytical Studies No. 55.
Services, Identified needs and recommendations following the April and May 2015 Earthquakes in Nepal
Global Conference on Primary Health Care From Alma-Ata towards universal health coverage and the Sustainable Development Goals
Astana, Kazakhstan, 25 and 26 October 2018
Scaling Up Mental Health Care In Rural India
Available in English, Russian and Ukrainian from the website
https://reliefweb.int/report/ukraine/ocha-ukraine-situation-report-22-october-2021-enruuk
This manual and its Excel tool are under revision. The revised edition will be published soon.
Cerebrum. 2016 Jul-Aug; 2016: cer-10-16.
Published online 2016 Jul 1.
Harm Reducation, Decriminalization and Zero Discrimination for People who use Drugs
Lancet Infect Dis 2022;
22: 222–4
Lancet Planet Health 2020; 4: e271–79
first issued 18 August 2022
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...that are intended for widespread utility throughout sub-Saharan Africa for treatment of envenoming irrespective of the species of snake causing a bite. Monovalent antivenoms for specific use cases: for products for a single species (or genus) of snake (e.g., boomslangs or carpet viper antivenoms).
Syndromic Pan-African polyvalent antivenoms for neurotoxic envenoming: products that are intended for treatment of envenoming by species whose venoms are neurotoxic. Syndromic Pan-African polyvalent antivenoms for non-neurotoxic envenoming: products for snakebite envenoming where the effects are largely haemorrhagic, necrotic or procoagulant.
more